Related Experiment Video
Updated: Sep 14, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic Impact of Different Definitions of White-Coat Hypertension
Paolo Verdecchia1, Stefano Coiro2, Claudia Bartolini2
1Associazione Umbra Cuore e Ipertensione and Division of Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy.
Insights
White-coat hypertension (WCH) carries low cardiovascular risk when defined by 24-hour ambulatory blood pressure (ABP) below 125/75 mmHg. Higher thresholds increase risks, highlighting the importance of precise WCH definitions for patient outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Epidemiology
Background:
- Variability in outcomes across white-coat hypertension (WCH) studies may stem from differing diagnostic definitions.
- Accurate WCH classification is crucial for predicting long-term cardiovascular risk.
Purpose of the Study:
- To investigate the long-term cardiovascular event and mortality risks associated with WCH using distinct 24-hour ambulatory blood pressure (ABP) thresholds.
- To clarify the prognostic implications of different WCH definitions.
Main Methods:
- A longitudinal study followed 3,153 individuals with office hypertension and 457 normotensive controls from 1986.
- Participants underwent 24-hour ABP monitoring; WCH was defined as average 24-hour ABP <130/80 mmHg or <125/75 mmHg.
- The primary outcome was a composite of major adverse cardiovascular events (MACE) and all-cause mortality over a mean 10.4-year follow-up.
Main Results:
- Compared to normotensives, individuals with WCH and 24-hour ABP <125/75 mmHg showed no increased risk of MACE (HR 0.94) or death (HR 1.37).
- However, WCH defined by 24-hour ABP <130/80 mmHg was associated with significantly higher MACE risk (HR 1.79) and all-cause mortality (HR 1.82).
Conclusions:
- Defining WCH using a stricter 24-hour ABP threshold (<125/75 mmHg) identifies individuals at low long-term risk for cardiovascular events and mortality.
- Elevated 24-hour ABP values even slightly above the <125/75 mmHg threshold are linked to increased cardiovascular risk, underscoring the clinical significance of precise diagnostic criteria.
Background:
Different definitions of white-coat hypertension (WCH) may explain its variable outcome across studies.
Methods:
In an Italian study started in 1986, we followed 3,153 people with (office blood pressure (BP) >=140/90 mmHg) and 457 without office hypertension for a mean of 10.4 years. None had previous cardiovascular disease. All underwent 24-h ambulatory BP (ABP) monitoring. We defined white-coat hypertension (WCH) as an average 24-h ABP < 130/80 mmHg or <125/75 mmHg. The primary outcome was a composite of major adverse cardiovascular events (MACE) and all-cause mortality.
Results:
Baseline office BP was 156/97 mmHg in people with and 127/81 mmHg without hypertension. At follow-up, MACE events were 344 and 23, and all-cause deaths were 318 and 24 in people with and without hypertension, respectively. Compared to normotensive group, MACE risk was not higher in people with WCH and 24-h ABP < 125/75 mmHg (hazard ratio (HR), 0.94; 95% confidence interval (CI), 0.42-2.10). Compared to normotensive group, MACE risk was higher in people with WCH and 24-h ABP < 130/80 mmHg (HR: 1.79; 95% CI, 1.07-2.29). All-cause death did not differ between the normotensive group and people with WCH and 24-h ABP < 125/75 mmHg (HR 1.37; 95% CI, 0.68-2.73), but it was higher than in the normotensive group when WCH was defined by a 24-h ABP < 130/80 mmHg (HR 1.82; 95% CI, 1.55-3.58).
Conclusions:
WCH defined by an average 24-h ABP < 125/75 mmHg identifies people at low risk of MACE and death in the long term. Even modestly above these threshold values, the risk associated with WCH increases.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Measurement of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension II: Pathophysiology

